Biotech Industry Executives To Deliver Solutions To Improve Cost Efficiency & Patient Care -- Tim Salaver, Bio Supply Management Alliance

Sept. 21, 2010 - PRLog -- The world's leading community for biotechnology supply chain professionals will meet on October 26, 2010 for the 3rd annual Biotech Supply Chain Academy conference at the Embassy Suites in South San Francisco titled “TRANSFORMING THE GLOBAL SUPPLY CHAIN FOR END-TO-END VISIBILITY & QUALITY PATIENT CARE". Biopharma industry leaders and solution providers will present initiatives in the areas of supply chain management, risk management, talent development, strategic sourcing, information technology network and cold chain. To register for the Conference, visit http://www.biosupplyalliance.org.

The current roster of confirmed speakers is below:

“Healthcare: Prospering in a Post-reform World”
o Karen Conway, Director – Industry Programs, Global Health Exchange (GHX)

“Uncovering the Unique Competencies of the Top 25 Healthcare Companies”
o Wayne McDonnell, Research Director, Healthcare & Life Science, Gartner

"Industry 360° - Transforming the Industry End To End” Panel
o Doug Witter, Vice President, Sales and Marketing, Owens & Minor Healthcare
o Jason Birnbaum, CIO, Global Supply Chain, GE Healthcare
o Chris Horan, Vice President, Supply Chain, North America, Genentech
o Andy Ramelmeier, Vice President, Manufacturing & Process Development, Bio-Marin
o Alison Moore, Vice President, Corporate Manufacturing, Amgen
o Vance Moore, President and CEO, Hospital Executive
o Moderator: Wayne McDonnell, Research Director. Life Sciences, Gartner

“Working Capital Management in the Global Enterprise: The Bottom Line!”
o Thomas Panzer, Vice President Global Supply Chain PS-Biotech, Bayer Healthcare

“Biotech Industry Risk Survey: The Lurking Dangers in Global Supply”
o William Coakley, Director, SciClone

"The Amplification Effects of Supply Chain Risks to Impact Shareholder Value - How Should this Affect a Business Strategy?"
o Chris Sam, Executive Director, Craigshannock
o Vijay Chiruvolu, Director, Risk Management, Amgen

“Risk Management Tools, Techniques, and Tribulations” Panel
o Jane Lavine, Risk Management Consultant
o Lew Kontnik, Director of Brand Protection, Amgen
o Thomas Smith, Director, Supply Chain Shir Pharmaceuticals
o Chris Sam, Executive Director, Craigshannock
o Yingming Yu, Associate Director, Nektar Therapeutics
o Carla Reed, Tunnell Consulting
o Moderator: William Coakley, Director, SciClone

“Key Learnings from Building a Raw Material Sourcing Risk Management Program”
o Yingming Yue, Associate Director, Supplier Management, Nektar

When something goes wrong with our supply chain, are we prepared to respond?’
o Jane Lavine, Life Sciences Risk Management Consultant, former VP of Life Science, Practice, Marsh

"Education Empowering People Excellence and World Class Performance"
o Keith Launchbury, CFPIM, President, APICS
o Muffie Dalton, CPIM, Team Leader, Drug Product Plant Scheduling, Genentech

“Meeting the Talent Development Challenges of the Biotech Industry”
o Muffie Dalton, Team Leader, Drug Product Plant Scheduling, Genentech
o Phil Kaminsky, Associate Professor, School of IE &OR, UC Berkeley
o Adam Zak, CEO, Adam Zak Executive Search
o Moderator: Dave Malenfant, Alcon Laboratories

"Leveraging Key Partners in Biopharma - R&D, CRO, CMO and Informatics”
o Dr. K. V. Subramaniam, President & CEO, Reliance International Life Sciences

“The Hospital Perspective of the Supply Chain”
o Vance Moore, President and CEO, OSi (Division of Sisters of Mercy)

“Sustainability of the Environment: A Profitable Strategy!”
o David Windsheimer, Vice President, Global Logistics, Life Technologies

“Progression from Tactical Purchasing to Strategic Sourcing”
o Paul Anderson, Vice President, Global Procurement, Life Technologies

“Global Strategic Sourcing: Combating Cost, Quality and Security of Supply”
o Mark Buck, Global Procurement and Supply Leader, Bio-Rad Laboratories
o Mike Mitchell, Director, Global Supply Chain Management, SAFC Bioscience
o Paul Anderson, Vice President, Global Sourcing, Life Technologies
o Dale Dwier, Manager, Procurement, Direct Materials, Bayer Healthcare
o Hung Truong, Manager, R&D Procurement, Genentech
o Moderator: William Coakley, Senior Director, Supply Chain Management, SciClone Pharmaceutical

“Timing &Tactics for Serialization in 2015: From Traceability to ePedigree”
o Ron Bone, Senior Vice President, Distribution Support, McKesson
o Lew Kontnik, Director, Brand Protection, Amgen

“Rewiring the Biotech Supply Chain: The Holy Grail!”
o Bruce Sawyer, Senior Director, Johnson & Johnson, Process Excellence
o Pramod John, Vice President, IT Strategy and Innovation, McKesson

“Pharma Industry Report: 2015 Readiness for Track and Trace”
o Robert Celeste, Director, GS1 Healthcare US

“Cold Chain Supply Chain: Proven Technologies and Practices” Panel
o Brian Wallin, Senior Packaging Engineer, Cold Chain Engineering, Amgen
o Ed Church, Executive Director, ISTA
o Don Wilson, Engineering Manager, Packaging & Containers, Amgen
o Jim Cox, CEO, TempTRIP, LLC
o Gary Hutchinson, Director, Global Transportation, Amgen
o Paul Harber, Associate Engineering Consultant, Eli Lilly
o Gordon L. Johnson II, Head of Strategic Innovation
o Moderator, Rod Derifield, President Envirocooler

# # #

The Bio Supply Management Alliance was born out of the need to create a worldwide community of operations and supply chain management leaders and professionals in the biotech, biopharma, and biomedical device industries. Based in the San Francisco Bay Area, home to more than 600 bio firms, the Alliance provides a forum for collaboration, learning and best practice sharing of practitioners, executives and thought leaders in these uniquely demanding industry sectors.

Founders Tim Salaver and Devendra Mishra have forged relationships with key industry leaders and defined initiatives with a vision to create process, people, procedure and policy improvements in this vital sector.

End